Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2003
12/02/2003US6657060 Neuropeptide Y antagonists; treatment of eating disorders such as obesity and hyperphagia
12/02/2003US6656959 PDE IV inhibiting pyridine derivatives
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656956 Benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656952 Cis-substituted fluoromethylpyrrolidine derivative
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656941 Altering the signal-transducing activity of GABAA receptors; diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and seizure disorders
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003CA2287046C Novel dihydroquinoline and tetrahydroquinoline compounds, process for preparing them and pharmaceutical compositions containing them
12/02/2003CA2249756C New indanol compounds, their preparation process and the pharmaceutical compositions containing them
11/2003
11/27/2003WO2003097855A2 Small molecule inhibitors of her2 expression
11/27/2003WO2003097636A1 Novel compounds and their use
11/27/2003WO2003097635A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
11/27/2003WO2003097634A1 Process for producing quinolonecarboxylic acid derivative
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097613A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003WO2003097612A1 Substituted 2-phenyl-3(2h)-pyridazinones
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097606A1 New method for the preparation of the anti-ulcer compounds omeprazole, lansoprazole and pantoprazole
11/27/2003WO2003097604A1 Pyridine carboxamide derivatives and their use as pesticides
11/27/2003WO2003097602A1 Cyanoguanidine produgs
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097598A1 Compound exhibiting pgd 2 receptor antagonism
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097564A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003WO2003097163A2 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003096991A2 Amelioration of the development of cataracts and other opthalmic diseases
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003035618A3 Modulators of phosphoinositide 3-kinase
11/27/2003WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2002074735A3 Biurethane derivatives
11/27/2003US20030220501 A chemical intermediates for making phthalimidoamlodipine, and further deprotecting to form amlodipine calcium channel blockers
11/27/2003US20030220496 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate
11/27/2003US20030220495 Inhibitors of farnesyl protein transferase
11/27/2003US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220423 A polymerization catalyst for free radical polymerization of ethylenically unsaturated monomers
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220373 Therapeutic uses of PPAR mediators
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220368 Superior Na+ channel inhibition activity; antiarrhythmic agents
11/27/2003US20030220366 Nicotinamide derivatives useful as PDE4 inhibitors
11/27/2003US20030220359 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
11/27/2003US20030220355 Useful as specific inhibitors of type-13 matrix mettaloprotease; for treating inflammatory conditions such as rheumatoid arthritis or osteoarthritis, and proliferative conditions such as cancers, particularly human breast cancer
11/27/2003US20030220348 Substituted imidazolylmethyl pyridine and pyrazine deriviatives GABAa receptor ligands
11/27/2003US20030220347 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220338 Fungal efflux pump inhibitors
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220327 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazephine as HIV reverse transcriptase inhibitors
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors
11/27/2003US20030220305 Substituted with pyridinylmethyl-, oxazolylmethyl-, imidazolylmethyl-, or thiazolylmethyl- groups
11/27/2003US20030220268 New phenylalanine derivatives
11/27/2003US20030220227 Bone disorders, cardiovascular diseases, anticholesterol agents, hypertriglyceridemia, vasomotor disorders, urogenital disorders, prostatic hypertrophy, endometrial hyperplasia, anticarcinogenic agents; CNS disorders; side effect reduced
11/27/2003US20030220198 2-pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses
11/27/2003US20030219844 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
11/27/2003CA2794297A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of amyloidosis
11/27/2003CA2794060A1 Methods and compositions using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of multiple myeloma
11/27/2003CA2752140A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-1-yl)-piperidine-2,6-dione for treatment and management of renal cancer
11/27/2003CA2752127A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of hepatocellular carcinoma
11/27/2003CA2752124A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of head and neck cancer
11/27/2003CA2752122A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of ovarian cancer
11/27/2003CA2727830A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
11/27/2003CA2727824A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of solid tumors
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2486061A1 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003CA2485896A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003CA2485589A1 Small molecule inhibitors of her2 expression
11/27/2003CA2484671A1 Cyanoguanidine prodrugs
11/27/2003CA2484512A1 Treatment of cataracts and other ophthalmic diseases
11/27/2003CA2484308A1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003CA2483619A1 Novel compounds and their use
11/27/2003CA2482151A1 Substituted 2-phenyl-3(2h)-pyridazinones
11/26/2003EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof
11/26/2003EP1363904A1 Pyrazoles as tgf inhibitors
11/26/2003EP1363903A1 Indole derivatives and their use as gnrh antagonists
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363901A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
11/26/2003EP1363900A1 Isoindole-imide compounds as tnf-inhibitors
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363889A1 Novel diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
11/26/2003EP1363888A2 Therapeutic acridone and acridine compounds
11/26/2003EP1363887A1 Substituted quinolinecarboxamides as antiviral agents
1 ... 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 ... 1080